Nutrition

PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support

Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical ResearchLas Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE)…

2 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or…

2 months ago

Stellar Health and CenterLight Healthcare Announce Partnership to Enable Providers And Improve Health Outcomes for New York Seniors

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Stellar Health, a healthcare technology company focused on revolutionizing value-based care, today announced…

2 months ago

New Research from Shed Reveals How Americans Are Really Trying to Lose Weight

From intermittent fasting to GLP-1s, Americans are rethinking how they lose weight—and what "healthy" really looks likeSALT LAKE CITY, Dec.…

2 months ago

Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina

The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health…

2 months ago

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:…

2 months ago

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq:…

2 months ago

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000…

2 months ago

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000…

2 months ago

Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary

With Human Studies On Every Formula, Qualia's Industry-Leading Research Standards Are Fueling Innovation and Rapid GrowthCARLSBAD, Calif., Dec. 9, 2025…

2 months ago